CLINICAL ROLE -
Finally, A Practical, Real-World Understanding of the Enhancing Oncology Model
The updated version of the Oncology Care Model (OCM) incentivizes value-based care over volume, but some wonder if it is enough.
RSV Vaccines for the Adult Patient
A panel of experts discuss RSV vaccination in adults.
RSV-Associated Impact in Health Care Systems
Drs Bridgeman and Welch highlight cost and resource impacts in health care systems driven by RSV.
Optimizing Clinical Pathways and Analyzing Quality of Life for Patients with MM
Multiple myeloma clinical pathways and factors affecting patient quality of life are explored by an expert panel.
Pharmacist Engagement in MM Treatment Landscape
Medical experts highlight the significant impact of pharmacists in multiple myeloma treatment pathways.
Experts Discuss the Important Role of Charitable Pharmacy Programs
Christina M. Madison, PharmD, FCCP, AAHIVP, sat down with Lydia Bailey, PharmD, BCACP, pharmacy operations manager at St. Vincent De Paul Charitable Pharmacy
Managing Pneumococcal Disease to Mitigate Community Infection
Mary Bridgeman, PharmD, BCPS, BCGP, FASCP, drives a discussion around preventative measures to limit the spread of pneumococcal infection.
Differential Diagnosis: Pneumococcal Pneumonia Versus Other Etiologies
William Schaffner, MD, and Christina Madison, PharmD, FCCP, AAHIVP provide an overview of the identification and differential diagnosis of pneumococcal pneumonia.
Recommended Flu Vaccines for Older Adults
An expert panel examines the distinctions among the 3 primary recommended flu vaccines for individuals aged 65 and above, assessing their efficacy compared with standard-dose flu vaccines.
Correlation Between Vaccines and Flu Transmissions
Adam C. Welch, PharmD, MBA, FAPhA, evaluates the impact of yearly flu vaccinations on curtailing the spread of influenza among communities and populations.
Second-Generation Combination Treatment Shows Long-Term Efficacy Against Advanced Kidney Cancer
With approximately 2 years of additional follow-up, lenvatinib plus pembrolizumab maintained robust effectiveness for nearly every patient.
Highlighting the Role of Proteosome Inhibitors in RRMM Treatment Pathways
Proteosome Inhibitors in Combination Therapy
Experts discuss the role of proteasome inhibitors in combination therapy in the management of relapsed indolent multiple myeloma.
Increasing Awareness of RSV Immunization Among Adults
Dr Madison provides insights on the importance of and strategies for raising awareness to adult RSV vaccines.
Evolution of RSV Treatment Strategies
Mary Bridgeman, PharmD, BCPS, BCGP, FASCP, Adam C. Welch, PharmD, MBA, FAPhA, and Christina Madison, PharmD, FCCP, AAHIVP, discuss the testing and treatment strategies for RSV.
Patients Most At Risk of Flu
A panel of experts discuss those most at risk for complications from the flu, and how flu vaccines may benefit them.
Patient Populations At High Risk for Pneumococcal Disease
High-risk patient populations for pneumococcal pneumonia are discussed by Christina Madison, PharmD, FCCP, AAHIVP.
Clinical and Economic Burdens Driving Novel Pneumococcal Vaccine Development
Key opinion leaders discuss factors leading to the development of novel pneumococcal vaccines.
Targeting Predominant Strains of Influenza
Experts examine the yearly modifications in the formulations of flu vaccines and explore the variations in the adverse events experienced across different types of flu vaccines.
Expert: Newly Approved Alzheimer Disease Drug is a "First Step"
Expert Nikhil Palekar, MD, said that although the treatment is far from a cure, it is a vital first step toward other treatments for Alzheimer Disease.
Clinical and Operational Differences: Proteasome Inhibitors Versus AntiCD38 Antibody Therapies
Experts navigate the impact of proteasome inhibitors and anti-CD38 antibody therapies in the relapsed refractory multiple myeloma treatment landscape.
Utilizing Three-Drug Regimen in MM Treatment
Experts highlight the use of 3- and 4-drug regimens for managing relapsed refractory multiple myeloma.
Examining the Incubation Period of RSV
The panel explores RSV infection susceptibility and transmission.
Expert: "Philosophical" About Pharmacy Services, How Community Health Worker Training Can Bolster Technician’s Role
Community health worker training can allow the technician to perform to the top of their abilities and improve access to the pharmacy’s public health services.
Risk Factors for Severe RSV Infection
Key opinion leaders discuss risk factors for RSV and patient populations most susceptible to the disease.
The Pandemic Introduced a Generation of People Who Turn to the Pharmacy As Additional Access Point To Care
COVID-19 is helping to shape current pharmacy practice, including increased vaccinations, access to care, and better interactions with patients.
Influenza Vaccine Development
An expert panel discusses the development of recombinant and cell-based vaccines and new types of influenza vaccines being explored.
Advancement of Influenza Vaccines
Experts review how influenza vaccines have advanced in recent years and discuss misconceptions that people may have about standard-dose and high-dose flu vaccines.
Signs and Symptoms of Pneumococcal Infections
Medical experts provide an overview of the signs and symptoms of pneumococcal infections.
Patient-Specific Factors Influencing MM Treatment Decisions
Key opinion leaders provide insight on patient considerations when formulating an optimal treatment regimen for multiple myeloma.
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Optimizing Clinical Pathways and Analyzing Quality of Life for Patients with MM")
